Concourse Financial Group Securities, Inc. Moderna, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.52 Billion
- Q1 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 799 shares of MRNA stock, worth $93,538. This represents 0.01% of its overall portfolio holdings.
Number of Shares
799
Previous 774
3.23%
Holding current value
$93,538
Previous $76,000
11.84%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding MRNA
# of Institutions
1,037Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.23 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.57 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.97 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.69 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.13 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...